Pharmaceuticals FDA approves Medtronic’s Simplera continuous glucose monitor; Abbott announces collaboration Last updated: August 7, 2024 6:43 pm By bexib 0 Min Read Share SHARE Partnership with Abbott on Simplera CGM expands access to advanced automated insulin dosing. You Might Also Like APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins New ways to determine drug value with health equity in mind Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer Share This Article Facebook Twitter Email Print Previous Article Bitcoin: Holdings exceed 0.1 BTC as price falls, approaching all-time high Next Article Investigation finds problems with enforcement of Buy America rules in controversial SEPTA contract Leave a comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Stay ConnectedFacebookLikeTwitterFollowYoutubeSubscribeTelegramFollowLatest News Selfridges ringing in the new year on the roof of San Carlo’s Alto Hospitality & Tourism Season 2024: Exceeding expectations at Borghese Contemporary Hotel Hospitality & Tourism JPMorgan and Bank of America respond to CFPB lawsuit Banking Zell says CFPB lawsuit against big banks is ‘regulatory overreach’ Banking
